Your browser doesn't support javascript.
loading
Assessment of hepatitis E seropositivity among HIV-infected patients in Bulgaria
Golkocheva-Markova, Elitsa; Kevorkyan, Ani; Raycheva, Ralitsa; Ismailova, Chiydem; Yoncheva, Viliana; Tenev, Tencho; Emilova, Radoslava; Grigorova, Lyubomira; Baltadzhiev, Ivan; Komitova, Radka.
  • Golkocheva-Markova, Elitsa; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Kevorkyan, Ani; Medical University-Plovdiv. Faculty of Public Health. Department of Epidemiology and Disaster Medicine. Plovdiv. BG
  • Raycheva, Ralitsa; Medical University -Plovdiv. Faculty of Public Health. Department of Social Medicine and Public Health. Plovdiv. BG
  • Ismailova, Chiydem; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Yoncheva, Viliana; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Tenev, Tencho; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Emilova, Radoslava; National Center of Infectious and Parasitic Diseases. Department of Immunology and Allergology. Sofia. BG
  • Grigorova, Lyubomira; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Baltadzhiev, Ivan; Medical University-Plovdiv. Faculty of medicine. Plovdiv. BG
  • Komitova, Radka; Medical University-Plovdiv. Faculty of medicine. Plovdiv. BG
Braz. j. infect. dis ; 26(1): 102329, 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1364547
ABSTRACT
Abstract It is debatable whether HIV-infected patients are at greater risk for hepatitis E virus (HEV) infection compared with healthy subjects. The reported anti-HEV seroprevalence among different groups in Bulgaria varied from 9.04% to 25.9%, but the information regarding the HIV population is still missing. The aim of the present study was to evaluate hepatitis E seroprevalence among HIV-infected patients in Bulgaria and to analyze demographic and immunological factors associated with HEV infection. Serum samples of 312 HIV-infected patients were analyzed retrospectively. Age, sex, residence and laboratory markers for HEV, HBV, HCV and HIV infection, and lymphocytes subpopulations were collected for all patients. None of the tested samples were positive for HEV RNA. HEV seroprevalence among HIV-infected patients was 10.9%. Males were more affected with the highest prevalence of positivity in the age group > 30 to ≤ 40 years. The documented HIV transmission routes in HIV/HEV co-infected group were heterosexual, homosexual, intravenous drug use (IDU), and vertical with predominace of the heterosexual route (z = 0.2; p = 0.804). There was a statistically significant trend of HIV mixed infection with routes of HIV transmission other than homosexual - heterosexual in HIV/HEV group and injection drug use in HIV/HBV/HCV co-infected group. The route of HIV transmission, in contexts of patients' behavior, was associated with HEV prevalence among HIV-infected patients.


Full text: Available Index: LILACS (Americas) Type of study: Risk factors Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2022 Type: Article / Project document Affiliation country: Bulgaria Institution/Affiliation country: Medical University -Plovdiv/BG / Medical University-Plovdiv/BG / National Center of Infectious and Parasitic Diseases/BG

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Type of study: Risk factors Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2022 Type: Article / Project document Affiliation country: Bulgaria Institution/Affiliation country: Medical University -Plovdiv/BG / Medical University-Plovdiv/BG / National Center of Infectious and Parasitic Diseases/BG